What does CUSIP 04746L104 represent in this 13F holders report?

CUSIP 04746L104 is the security identifier for ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value used to aggregate holder disclosures.

How many institutions held ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in Q4 2022?

92 institutional investors reported ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value for Q4 2022. Use the holders table for investor-level position and value details.

Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)

CUSIP: 04746L104

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock, $0.0001 Par Value
Shares outstanding: 9,614,000
Total 13F shares: 21,791,013
Share change: +819,088
Total reported value: $69,074,070
Put/Call ratio: 14%
Price per share: $3.17
Number of holders: 92
Value change: +$2,745,077
Number of buys: 50
Number of sells: 34

Quarterly Holders Quick Answers

What is CUSIP 04746L104?
CUSIP 04746L104 identifies ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 04746L104:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PERCEPTIVE ADVISORS LLC	13F	Company	50%	4,797,278	$14,248,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	27%	2,591,089	$7,695,000	—	30 Sep 2022	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	20%	1,878,000	$5,578,000	—	30 Sep 2022	13F
VANGUARD GROUP INC	13F	Company	19%	1,832,030	$5,441,000	—	30 Sep 2022	13F
PATHSTONE FAMILY OFFICE, LLC	13F	Company	19%	1,815,540	$5,392,154	—	30 Sep 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	11%	1,040,834	$3,091,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	8.1%	782,154	$2,323,000	—	30 Sep 2022	13F
Bristlecone Advisors, LLC	13F	Company	7.3%	700,926	$2,082,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	6.2%	592,704	$1,760,000	—	30 Sep 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	5.1%	489,254	$1,453,000	—	30 Sep 2022	13F
Hudson Bay Capital Management LP	13F	Company	4.8%	458,900	$1,363,000	—	30 Sep 2022	13F
CITADEL ADVISORS LLC	13F	Company	4.6%	440,781	$1,309,000	—	30 Sep 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	3.8%	360,643	$1,071,000	—	30 Sep 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	3.6%	347,400	$1,032,000	—	30 Sep 2022	13F
Nuveen Asset Management, LLC	13F	Company	1.2%	113,794	$961,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	2.9%	276,293	$820,000	—	30 Sep 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	2.6%	251,935	$748,000	—	30 Sep 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2.4%	235,003	$698,000	—	30 Sep 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	2.3%	219,472	$652,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	2.1%	197,244	$586,000	—	30 Sep 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	1.8%	169,518	$503,000	—	30 Sep 2022	13F
BARCLAYS PLC	13F	Company	1.7%	166,768	$495,000	—	30 Sep 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.7%	159,700	$474,000	—	30 Sep 2022	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	1.5%	139,924	$416,000	—	30 Sep 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	1.4%	136,019	$404,000	—	30 Sep 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	1.3%	128,122	$381,000	—	30 Sep 2022	13F
Laird Norton Wetherby Trust Company, LLC	13F	Company	1.2%	120,000	$356,000	—	30 Sep 2022	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	110,100	$327,000	—	30 Sep 2022	13F
Bank of New York Mellon Corp	13F	Company	1.1%	109,766	$326,000	—	30 Sep 2022	13F
XTX Topco Ltd	13F	Company	0.96%	91,875	$273,000	—	30 Sep 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.92%	88,802	$264,000	—	30 Sep 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.8%	76,600	$228,000	—	30 Sep 2022	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.73%	69,770	$207,000	—	30 Sep 2022	13F
UBS Group AG	13F	Company	0.68%	65,122	$193,000	—	30 Sep 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.66%	63,581	$189,000	—	30 Sep 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.65%	62,803	$187,000	—	30 Sep 2022	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.64%	61,222	$182,000	—	30 Sep 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.52%	50,455	$150,000	—	30 Sep 2022	13F
IEQ CAPITAL, LLC	13F	Company	0.52%	49,922	$148,000	—	30 Sep 2022	13F
MARTINGALE ASSET MANAGEMENT L P	13F	Company	0.42%	40,107	$120,000	—	30 Sep 2022	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.37%	36,045	$107,000	—	30 Sep 2022	13F
ALGERT GLOBAL LLC	13F	Company	0.37%	35,190	$105,000	—	30 Sep 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.36%	34,542	$102,000	—	30 Sep 2022	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.36%	34,509	$102,000	—	30 Sep 2022	13F
EASTERLY INVESTMENT PARTNERS LLC	13F	Company	0.35%	33,500	$99,000	—	30 Sep 2022	13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	13F	Company	0.35%	33,500	$99,000	—	30 Sep 2022	13F
Clarius Group, LLC	13F	Company	0.34%	32,825	$97,000	—	30 Sep 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.32%	30,524	$91,000	—	30 Sep 2022	13F
Rockefeller Capital Management L.P.	13F	Company	0.31%	30,100	$89,000	—	30 Sep 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.3%	28,623	$85,000	—	30 Sep 2022	13F

Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q4 2022

As of 31 Dec 2022, Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by 92 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,791,013 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, STATE STREET CORP, BML Capital Management, LLC, Bristlecone Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, and CITADEL ADVISORS LLC. This page lists 92 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

-2

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.